Robert Matthew Lutz
CIK 1786203 · Chief Operating Officer · last filed 2025-12-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.72M
Companies
3
Total Filings
13
Lifetime Open-Market Net
-$8.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SVRA | Chief Operating Officer | 293,977 | $5.26 | $1.55M | $0 | 5 | 2025-12-16 |
| IBIO | See Remarks | 102,165 | $1.69 | $172.7K | -$8.5K | 5 | 2022-11-15 |
| Strongbridge Biopharma plc (SBBP) Delisted | Chief Financial Officer | 181,333 | $2.00 | $362.7K | $0 | 3 | 2021-02-23 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-23 | Strongbridge Biopharma plc (SBBP) Delisted | Tax (F) | −6,978 | -$25.3K | EDGAR |
| 2021-01-08 | Strongbridge Biopharma plc (SBBP) Delisted | Grant (A) | +147,500 | $0 | EDGAR |
| 2020-01-29 | Strongbridge Biopharma plc (SBBP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.